CTCBIO Inc. (KOSDAQ:060590)
4,320.00
+70.00 (1.65%)
At close: Feb 20, 2026
CTCBIO Market Cap
CTCBIO has a market cap or net worth of 101.61 billion as of February 20, 2026. Its market cap has decreased by -36.57% in one year.
Market Cap
101.61B
Enterprise Value
122.04B
Revenue
132.76B
Ranking
n/a
PE Ratio
38.31
Stock Price
4,320.00
Market Cap Chart
Since March 3, 2003, CTCBIO's market cap has increased from 10.66B to 101.61B, an increase of 853.52%. That is a compound annual growth rate of 10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 101.61B | -8.11% |
| Dec 30, 2025 | 110.58B | -29.39% |
| Dec 30, 2024 | 156.60B | -38.79% |
| Dec 28, 2023 | 255.82B | 69.84% |
| Dec 29, 2022 | 150.63B | -28.80% |
| Dec 30, 2021 | 211.56B | 32.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 134.70B |
| TegoScience | 115.86B |
| KoBioLabs | 105.06B |
| IMGT Co.,Ltd. | 104.97B |
| Naturalendo Tech | 94.25B |
| Cell Biotech | 94.10B |
| Progen | 93.48B |
| Choong Ang Vaccine Laboratory | 92.32B |